BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38084732)

  • 1. Insulin-like growth factor 2 mRNA-binding protein 2 is a therapeutic target in ovarian cancer.
    Yuan J; Li X; Wang F; Liu H; Guan W; Xu G
    Exp Biol Med (Maywood); 2023 Dec; 248(23):2198-2209. PubMed ID: 38084732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IGF2BP2 maybe a novel prognostic biomarker in oral squamous cell carcinoma.
    Wang X; Xu H; Zhou Z; Guo S; Chen R
    Biosci Rep; 2022 Feb; 42(2):. PubMed ID: 35129592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic marker C3AR1 is associated with ovarian cancer cell proliferation and immunosuppression in the tumor microenvironment.
    Huang J; Zhou L; Deng K
    J Ovarian Res; 2023 Apr; 16(1):64. PubMed ID: 37005667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analyses Identify APOBEC3A as a Genomic Instability-Associated Immune Prognostic Biomarker in Ovarian Cancer.
    Xu F; Liu T; Zhou Z; Zou C; Xu S
    Front Immunol; 2021; 12():749369. PubMed ID: 34745121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative analysis of cuproptosis-associated genes for predicting immunotherapy response in single-cell and multi-cohort studies.
    Li H; Wang Y; Li G; Xiong J; Qin L; Wen Q; Yue C
    J Gene Med; 2024 Jan; 26(1):e3600. PubMed ID: 37776237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hsa_circ_0001756 promotes ovarian cancer progression through regulating IGF2BP2-mediated RAB5A expression and the EGFR/MAPK signaling pathway.
    Ji J; Li C; Wang J; Wang L; Huang H; Li Y; Fang J
    Cell Cycle; 2022 Apr; 21(7):685-696. PubMed ID: 35113003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Knockdown of IGF2BP2 inhibits colorectal cancer cell proliferation, migration and promotes tumor immunity by down-regulating MYC expression].
    Liu T; Han C; Hu C; Mao S; Sun Y; Yang S; Yang K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Apr; 39(4):303-310. PubMed ID: 37087547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of CALD1 predicted a poor prognosis for platinum-treated ovarian cancer and revealed it as a potential therapeutic resistance target.
    BMC Genomics; ; . PubMed ID: 38365611
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.